Cart
0
Something genuinely historic is happening in the UK CBD industry, and hardly anyone outside it has noticed.
Since 2019, every CBD oil, capsule, gummy and drink sold in England and Wales has existed in a strange regulatory waiting room called the novel foods process — on sale, tolerated, but never actually authorised. That's about to change. For the first time ever, the Food Standards Agency has consulted on authorising specific CBD products, and the first full authorisations are expected to take effect this year.
Here's what's happening, in plain English — and what it means for you as a CBD buyer.
A quick recap: why CBD foods were in limbo
In January 2019, CBD extracts were classified as "novel foods" — foods without a significant history of consumption in the EU before 1997. Novel foods need pre-market safety authorisation. Rather than pull thousands of products off shelves, the FSA created a pragmatic compromise: a public list of CBD products allowed to stay on sale while their safety dossiers worked through the system.
That compromise has now lasted seven years. Products on the list are legal to sell but not formally approved; products off the list shouldn't be sold at all. It's been messy, slow, and confusing for shoppers — which is exactly why the next step matters.
The breakthrough: RP07, RP350 and RP427
Three application dossiers — catchily named RP07, RP350 and RP427 — became the first ever to pass the FSA's full risk assessment. Two received positive safety assessments in April 2025, the third in August 2025, and the FSA then launched a public consultation on recommending authorisation to ministers in England and Wales.
If ministers sign off — and the industry expectation, per Cannabis Health News, is that authorisations land in 2026 — the products attached to those dossiers become the first fully regulated CBD foods in British history. Not tolerated. Not "pending". Authorised, with legally defined specifications and labelling.
What will actually change for shoppers
- Clearer labels. Authorised products will carry standardised information about safe use — including the FSA's advice of a provisional acceptable daily intake of 10mg CBD per day for food products.
- A real quality bar. Authorisation is tied to precise product specifications. Products that can't demonstrate they match an authorised spec will find it increasingly hard to stay on shelves.
- A market clean-out. Thousands of listed products that never completed their dossiers are likely to fall away. Expect fewer, better CBD food products — and more scrutiny of the ones that remain.
Important: flower, hash and botanicals sit outside this entirely
Here's the part that confuses people. The novel foods regime covers CBD ingestible products — oils, capsules, drinks, edibles. It does not cover products that aren't sold as food.
CBD flower and CBD hash are sold as aromatic botanical products, not foods, so the FSA authorisation process doesn't apply to them. Their legal position rests instead on THC content and hemp sourcing rules — we cover this fully in our guides to CBD flower and UK law and whether CBD hash is legal in the UK.
What the two worlds share is the thing that actually protects you as a buyer: lab testing. Whether it's an FSA-authorised oil or a botanical hemp product, the Certificate of Analysis is the document that proves what's in it. It's why we publish a COA for every product we sell.
Our take: regulation is good for buyers — and good for the honest end of the industry
Some corners of the CBD world are nervous about authorisation, because a real quality bar is expensive to clear. We think it's overdue. The industry's biggest problem has never been regulation — it's been the mystery products with made-up strengths that erode trust in everyone else. A market where claims have to be proven is a market where good products win.
Between FSA authorisation on the food side and honest lab reporting on the botanical side, 2026 is shaping up to be the year UK CBD finally grows up.
FAQs
Are CBD products currently legal in the UK?
Yes — CBD itself is legal. Ingestible CBD products must be linked to the FSA's public list while authorisation completes; botanical products like flower and hash are governed by separate THC and hemp-sourcing rules.
What are RP07, RP350 and RP427?
They're the three CBD novel food application dossiers that first passed the FSA's safety assessment and were put forward for ministerial authorisation — set to become the UK's first fully authorised CBD food products.
How much CBD does the FSA say is safe per day?
The FSA's current advice for healthy adults is a provisional acceptable daily intake of 10mg of CBD per day from food products — a conservative figure based on lifetime daily consumption.
Does FSA authorisation affect CBD flower or hash?
No. The novel foods process only covers food products. Flower and hash are sold as botanical products and sit outside it — their key compliance measure is THC content, verified by lab testing.
Sources: Food Standards Agency, FSA public list of CBD products, Cannabis Health News, Food Safety Magazine. General information, not legal or medical advice.
